1 |
Imm RN, Muñoz-benitez J, Medina D, Barcenas E, Molero-castillo G, Reyes-ortega P, Hughes-cano JA, Medrano-gracia L, Miranda-anaya M, Rojas-piloni G, Quiroz-mercado H, Hernández-zimbrón LF, Fajardo-cruz ED, Ferreyra-severo E, García-franco R, Mijangos JFR, López-star E, García-roa M, Lansingh VC, Thébault SC. Preventable risk factors for type 2 diabetes can be detected using noninvasive spontaneous electroretinogram signals.. [DOI: 10.21203/rs.3.rs-2260811/v1] [Reference Citation Analysis]
|
2 |
Sierawska O, Niedźwiedzka-rystwej P. Adipokines as potential biomarkers for type 2 diabetes mellitus in cats. Front Immunol 2022;13:950049. [DOI: 10.3389/fimmu.2022.950049] [Reference Citation Analysis]
|
3 |
Górnicka M, Szewczyk K, Białkowska A, Jancichova K, Habanova M, Górnicki K, Hamulka J. Anthropometric Indices as Predictive Screening Tools for Obesity in Adults; The Need to Define Sex-Specific Cut-Off Points for Anthropometric Indices. Applied Sciences 2022;12:6165. [DOI: 10.3390/app12126165] [Reference Citation Analysis]
|
4 |
Reynés B, Cifre M, Palou A, Oliver P. Perinatal Treatment with Leptin, but Not Celastrol, Protects from Metabolically Obese, Normal-Weight Phenotype in Rats. Nutrients 2022;14:2277. [DOI: 10.3390/nu14112277] [Reference Citation Analysis]
|
5 |
Mitu I, Preda C, Dimitriu CD, Mitu O, Costache II, Ciocoiu M. Metabolic Phenotypes—The Game Changer in Quality of Life of Obese Patients? Healthcare 2022;10:617. [DOI: 10.3390/healthcare10040617] [Reference Citation Analysis]
|